New explortion of 5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazole-4-methanol

We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 946426-89-7, and how the biochemistry of the body works.COA of Formula: C13H11Cl2NO2

In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 946426-89-7, name is 5-Cyclopropyl-3-(2,6-dichlorophenyl)isoxazole-4-methanol, introducing its new discovery. COA of Formula: C13H11Cl2NO2

Heterocyclic french Nepal ester derivatives X receptor modulators (by machine translation)

The invention relates to a heterocyclic compound and contains the same component composition preparation method and its as french Nepal ester X receptor (FXR) derivatives of the active use of the regulator, the regulator shown in formula I of the heterocyclic compound, or its pharmaceutically acceptable salt, prodrug, compound solvent, polymorphism body, isomer, and stable isotope derivatives. The invention relates to compounds can be used for the treatment or prevention of the diseases related to the FXR-mediated by, the related disease is due to the carbohydrate, lipid or bile metabolism caused by abnormal. (by machine translation)

We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 946426-89-7, and how the biochemistry of the body works.COA of Formula: C13H11Cl2NO2

Reference£º
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem